Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

INTUITIVE SURGICAL INC Director's Dealing 2025

May 2, 2025

29809_dirs_2025-05-01_adbedbe8-0947-4e9b-b81a-6a1dcce00cc8.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INTUITIVE SURGICAL INC (ISRG)
CIK: 0001035267
Period of Report: 2025-04-30

Reporting Person: Ladd Amy L (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-04-30 Common Stock M 1448 $243.26 Acquired 2858 Direct
2025-04-30 Common Stock S 1448 $505.5459 Disposed 1410 Direct
2025-04-30 Common Stock M 1671 $286.5533 Acquired 3081 Direct
2025-04-30 Common Stock S 1671 $505.5459 Disposed 1410 Direct
2025-04-30 Common Stock M 2298 $171.0733 Acquired 3708 Direct
2025-04-30 Common Stock S 2298 $505.5459 Disposed 1410 Direct
2025-04-30 Common Stock M 1650 $171.2 Acquired 3060 Direct
2025-04-30 Common Stock S 1650 $505.5459 Disposed 1410 Direct
2025-04-30 Common Stock M 1709 $295.92 Acquired 3119 Direct
2025-04-30 Common Stock S 1709 $505.5459 Disposed 1410 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-04-30 Non-Qualified Stock Option (right to buy) $171.0733 M 2298 Disposed 2030-04-23 Common Stock (2298) Direct
2025-04-30 Non-Qualified Stock Option (right to buy) $171.2 M 1650 Disposed 2029-08-02 Common Stock (1650) Direct
2025-04-30 Non-Qualified Stock Option (right to buy) $243.26 M 1448 Disposed 2029-04-27 Common Stock (1448) Direct
2025-04-30 Non-Qualified Stock Option (right to buy) $286.5533 M 1671 Disposed 2031-04-22 Common Stock (1671) Direct
2025-04-30 Non-Qualified Stock Option (right to buy) $295.92 M 1709 Disposed 2030-04-26 Common Stock (1709) Direct
2025-05-01 Restricted Stock Units $0.0 A 531 Acquired Common Stock (531) Direct

Footnotes

F1: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on January 29, 2026.

F2: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $502.49 to $509.99 as follows: 1,758 shares sold at $502.49 to $503.39; 1,542 shares sold at $503.81 to $504.79; 1,951 shares sold at $504.83 to $505.77; 1,845 shares sold at $505.88 to $506.53; 610 shares sold at $506.90 to $507.84; and 1,070 shares sold at $509.99. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

F3: 100% of the shares subject to the option shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting
Person's continued service as a director to the issuer.

F4: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service.